FDA says Gottlieb statement does not signal CBD enforcement shift, but some questions unanswered, observers say
A statement by FDA Commissioner Dr. Scott Gottlieb on the approval of a CBD drug has left some industry stakeholders wondering what the exact implications are for the many CBD products being marketed as dietary supplements.